Jaguar Health (JAGX) Non Operating Income (2015 - 2026)
Jaguar Health (JAGX) reported Non Operating Income of $205000.0 for Q1 2026, up 83.04% year-over-year from $112000.0 in Q1 2025, and up 169.02% quarter-over-quarter from -$297000.0 in Q4 2025.
Jaguar Health (JAGX) Non Operating Income (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Non Operating Income data on file, last reported at $205000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $205000.0, up 83.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $136000.0 (up 291.55% YoY), and the FY2025 annual result was $43000.0, down 15.69% from the prior year.
- Non Operating Income grew to $205000.0 in Q1 2026 per JAGX's latest filing, from -$297000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.4 million in Q4 2022 and troughed at -$1.1 million in Q2 2022.
- A 5-year average of $85235.3 and a median of $112000.0 in 2025 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 8220.0% in 2022 and fell as far as 6276.47% in 2022.
- A 5-year view of Non Operating Income shows it stood at $1.4 million in 2022, then plunged by 81.18% to $256000.0 in 2023, then jumped by 47.66% to $378000.0 in 2024, then tumbled by 178.57% to -$297000.0 in 2025, then surged by 169.02% to $205000.0 in 2026.
- Business Quant data shows JAGX's Non Operating Income at $205000.0 in Q1 2026, -$297000.0 in Q4 2025, and -$94000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 9.35 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | 322,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -729,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | -158,000.00 |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | 832,000.00 |
| Dec 31, 2021 | -749,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -17,000.00 |